Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Green

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Bone|July 18, 2006
A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in ratsJürg A Gasser, Jonathan R Green, Victor Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acidJeanette Wood, Karine Bonjean, Stephan Ruetz, et al.
Arthritis and Rheumatism|July 13, 2004
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritisNatalie A Sims, Jonathan R Green, Markus Glatt, et al.
Plos One|January 1, 2015
Whale shark (Rhincodon typus) seasonal presence, residence time and habitat use at darwin island, galapagos marine reserveDavid Acuña-Marrero, Jesús Jiménez, Franz Smith, et al.
International Journal of Cancer|July 22, 2009
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylationAndreas Guenther, Sharon Gordon, Markus Tiemann, et al.
Ecology|October 28, 2021
Sharks as exfoliators: widespread chafing between marine organisms suggests an unexplored ecological roleLacey H Williams, Alexandra Anstett, Victor Bach Muñoz, et al.
Chemmedchem|August 8, 2006
Structural basis for the exceptional in vivo efficacy of bisphosphonate drugsJean-Michel Rondeau, Francis Bitsch, Emmanuelle Bourgier, et al.
Bone|May 1, 2020
ZoledronateIan R Reid, Jonathan R Green, Kenneth W Lyles, et al.
Angewandte Chemie (International Ed. in English)|October 13, 2015
A General Strategy for Targeting Drugs to BoneWolfgang Jahnke, Guido Bold, Andreas L Marzinzik, et al.
Journal of Medicinal Chemistry|August 9, 2002
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa)Leo Widler, Knut A Jaeggi, Markus Glatt, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Bone|July 18, 2006
A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in ratsJürg A Gasser, Jonathan R Green, Victor Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acidJeanette Wood, Karine Bonjean, Stephan Ruetz, et al.
Arthritis and Rheumatism|July 13, 2004
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritisNatalie A Sims, Jonathan R Green, Markus Glatt, et al.
Plos One|January 1, 2015
Whale shark (Rhincodon typus) seasonal presence, residence time and habitat use at darwin island, galapagos marine reserveDavid Acuña-Marrero, Jesús Jiménez, Franz Smith, et al.
International Journal of Cancer|July 22, 2009
The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylationAndreas Guenther, Sharon Gordon, Markus Tiemann, et al.
Ecology|October 28, 2021
Sharks as exfoliators: widespread chafing between marine organisms suggests an unexplored ecological roleLacey H Williams, Alexandra Anstett, Victor Bach Muñoz, et al.
Chemmedchem|August 8, 2006
Structural basis for the exceptional in vivo efficacy of bisphosphonate drugsJean-Michel Rondeau, Francis Bitsch, Emmanuelle Bourgier, et al.
Bone|May 1, 2020
ZoledronateIan R Reid, Jonathan R Green, Kenneth W Lyles, et al.
Angewandte Chemie (International Ed. in English)|October 13, 2015
A General Strategy for Targeting Drugs to BoneWolfgang Jahnke, Guido Bold, Andreas L Marzinzik, et al.
Journal of Medicinal Chemistry|August 9, 2002
Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa)Leo Widler, Knut A Jaeggi, Markus Glatt, et al.
Pageof 4